|
InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma |
|
|
|
Title: |
InterPATH-001 trial in progress: Adjuvant V940 (mRNA-4157) with pembrolizumab versus placebo in patients with high-risk stage II-IV melanoma |
Author: |
Weber, J.S. Luke, J.J. Carlino, M.S. Khattak, M.A. Meehan, R. Brown, M. Zhang, J. Krepler, C. Duic, J.P. Long, G.V. |
Appeared in: |
EJC skin cancer |
Paging: |
Volume 2 () nr. S1 pages p. |
Year: |
2024 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|